Rheumatology Doctors in Astoria, NY Accepting Medicare

5 Rheumatology doctors found. Showing 1 - 5

Dr. Jonathan Paramo, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3016 30th Dr Ste 1b, Astoria, NY 11102 Phone: 516-708-2550    Fax: 516-708-2597

Milagros Hernandez, M.D Internal Medicine - Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 3010 38th St, Astoria, NY 11103 Phone: 718-545-2424    Fax: 718-932-9131

Dr. Micaela F Bayard, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2520 30th Ave Fl 5, Astoria, NY 11102 Phone: 718-808-7777    Fax: 718-808-7757

Dimitrios Asters, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4401 Newtown Rd, Astoria, NY 11103 Phone: 718-728-2555

Dr. Stelios Viennas, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3802 31st Ave, Astoria, NY 11103 Phone: 718-728-5951    Fax: 718-728-1624

News Archive

AnaptysBio awarded DARPA contract to generate novel high affinity thermally stable antibodies

AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced it has been awarded a contract by the Defense Advanced Research Projects Agency (DARPA), to use its proprietary somatic hypermutation (SHM) technology platform to generate novel high affinity thermally stable antibodies that could be used by the military in antibody-based biosensors, including those that can detect bioterrorist threats.

T-System to deploy NextGen Practice Management solution to optimize revenue cycle

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today that T-System, Inc., will deploy NextGen® Practice Management to help drive revenue cycle management billing for its clients, which span across the U.S.

Microvisk introduces unique handheld device which monitors blood clotting status

Microvisk Technologies has introduced its unique handheld devices which monitor the blood clotting status of patients to the US market. Showcased at the prestigious American Association for Clinical Chemistry annual conference, the Microvisk devices attracted strong interest from distributors and potential partners ahead of clinical trials in major US medical centres this autumn and product launches in 2012.

Baylor Health Care System raises awareness about atrial fibrillation

An estimated 2.5 million Americans suffer from irregular heartbeats-also known as atrial fibrillation. Baylor Health Care System is raising awareness about this often misunderstood, but potentially life changing cardiovascular condition whose incidence is on the rise and expected to more than double by 2050.

Read more Medical News

› Verified 5 days ago